Inogen
Corporate Headquarters
326 Bollay Drive
Goleta
California
93117
United States
Tel: 805-562-0500
Website: http://www.inogen.net/
Email: info@inogen.net
188 articles about Inogen
-
Inogen Strengthens Board of Directors with Addition of Kristen Miranda
2/16/2021
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Kristen Miranda has been appointed to its Board of Directors, effective March 1, 2021. In addition, Ms. Miranda was appointed to the Board’s Compensation Committee.
-
Inogen Announces Participation in the 10th Annual SVB Leerink Global Healthcare Conference
2/10/2021
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 10th Annual SVB Leerink Healthcare Conference.
-
Inogen to Announce Fourth Quarter and Year End 2020 Financial Results on February 24th, 2021
2/9/2021
Inogen to Announce Fourth Quarter and Year End 2020 Financial Results on February 24 th , 2021
-
Inogen Announces CEO Transition
1/27/2021
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Nabil Shabshab as Inogen’s President and Chief Executive Officer (“CEO”), effective February 8, 2021
-
Inogen Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference
12/18/2020
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 39th Annual J.P. Morgan Healthcare Conference
-
Inogen Announces Participation in the Stifel 2020 Virtual Healthcare Conference
11/10/2020
Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the Stifel 2020 Virtual Healthcare Conference. Inogen’s President and CEO, Scott Wilkinson, and CFO, Alison Bauerlein, are scheduled to present on Tuesday, November 17 th , 2020 at 4:00 p.m. EST at the Stifel 2020
-
Inogen Announces Third Quarter 2020 Financial Results
11/4/2020
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended September 30, 2020.
-
Inogen to Announce Third Quarter 2020 Financial Results on Wednesday, November 4th, 2020
10/14/2020
Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2020 financial results after market close on Wednesday, November 4 th , 2020. The Company will host a corresponding conference call beginning at 1:30pm PT
-
Inogen Announces Second Quarter 2020 Financial Results
8/4/2020
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended June 30, 2020.
-
Inogen to Announce Second Quarter 2020 Financial Results on Tuesday, August 4th, 2020
7/7/2020
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2020 financial results after market close on Tuesday, August 4th, 2020.
-
Inogen CEO Announces Intent to Retire Before End of 2021; Inogen Commences Search for Successor
6/9/2020
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that in connection with Inogen’s succession planning activities, Scott Wilkinson, the Company’s Chief Executive Officer and President, has informed the Company’s Board of Directors
-
Inogen Announces Participation in the 40th Annual William Blair Growth Stock Conference
6/3/2020
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 40th Annual William Blair Growth Stock Conference.
-
Inogen Announces First Quarter 2020 Financial Results
5/5/2020
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended March 31, 2020.
-
Inogen to Announce First Quarter 2020 Financial Results on Tuesday, May 5, 2020
4/21/2020
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2020 financial results after market close on Tuesday, May 5, 2020.
-
Inogen, Inc. Announces Change of Date, Time and Location of 2020 Annual Meeting of Stockholders to Virtual-Only Annual Meeting
4/14/2020
Inogen, Inc. announced that due to the public health impact of the coronavirus pandemic, and to support the health and well-being of its employees, stockholders, and other meeting participants, the company has changed the date, time and format of its 2020 Annual Meeting of Stockholders.
-
Inogen Announces Fourth Quarter and Full Year 2019 Financial Results and Updates 2020 Guidance
2/25/2020
Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, reported financial results for the three-month and twelve-month periods ended December 31, 2019.
-
Inogen Announces Participation in the 9th Annual Leerink Partners Global Healthcare Conference
2/5/2020
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 9th Annual Leerink Partners Global Healthcare Conference in New York City.
-
Inogen to Announce Fourth Quarter and Full Year 2019 Financial Results on Tuesday, February 25, 2020
1/28/2020
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter and full year 2019 financial results after market close on Tuesday, February 25, 2020
-
Inogen Announces Preliminary, Unaudited Full Year and Fourth Quarter 2019 Revenue Results
1/13/2020
Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, reported preliminary unaudited revenue results for the three-month and twelve-month periods ended December 31, 2019.
-
Inogen Announces Participation in the 38th Annual J.P. Morgan Healthcare Conference
12/31/2019
Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that the Company’s management will be participating in the 38th Annual J.P. Morgan Healthcare Conference in San Francisco.